Patient preferences and health state utilities associated with the treatment process of antiretroviral therapy for people living with HIV

被引:0
作者
Louis S. Matza
Timothy A. Howell
Vasiliki Chounta
Nicolas van de Velde
机构
[1] Patient-Centered Research,
[2] Global Health Outcomes,undefined
[3] Formerly With Global Health Outcomes,undefined
来源
Quality of Life Research | 2023年 / 32卷
关键词
Health state utility; Treatment process utility; Utility; Route of administration; HIV; Antiretroviral therapy; Long-acting injectable;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:531 / 541
页数:10
相关论文
共 173 条
[1]  
Arts EJ(2012)HIV-1 antiretroviral drug therapy Cold Spring Harbor Perspectives in Medicine 2 a007161-839
[2]  
Hazuda DJ(2016)Antiretroviral therapy for the prevention of HIV-1 transmission New England Journal of Medicine 375 830-71
[3]  
Cohen MS(2017)Long-acting antiretrovirals: Where are we now? Current HIV/AIDS Reports 14 63-26
[4]  
Chen YQ(2021)Undetectable equals untransmittable (U=U): Awareness and associations with health outcomes among people living with HIV in 25 countries Sexually Transmitted Infections 97 18-194
[5]  
McCauley M(2018)Prevalence and patterns of antiretroviral therapy prescription in the United States The Open AIDS Journal 12 181-490
[6]  
Nyaku AN(2019)Adherence to HIV treatment regimens: Systematic literature review and meta-analysis Patient Preference and Adherence 13 475-17
[7]  
Kelly SG(2014)Single-tablet regimens in HIV therapy Infectious Disease and Therapy 3 1-271
[8]  
Taiwo BO(2014)HIV infection: Epidemiology, pathogenesis, treatment, and prevention Lancet 384 258-932
[9]  
Okoli C(2017)Dual antiretroviral therapy for HIV infection Expert Opinion on Drug Safety 16 923-18
[10]  
Van de Velde N(2020)Quantifying people living with HIV who would benefit from an alternative to daily oral therapy: Perspectives from HIV physicians and people living with HIV Population Medicine 2 1-1189